ID: ALA177904

Max Phase: Preclinical

Molecular Formula: C48H78N8O11

Molecular Weight: 943.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC[C@H](C)[C@H](NC(=O)[C@H](C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)N(C)C(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)OC(C)(C)C)C(C)C)C(=O)NC(CO)(CO)CO

Standard InChI:  InChI=1S/C48H78N8O11/c1-11-31(6)40(44(64)54-48(25-57,26-58)27-59)53-41(61)34(30(4)5)23-39(60)35(20-29(2)3)51-43(63)38(22-33-24-49-28-50-33)55(10)45(65)36(21-32-16-13-12-14-17-32)52-42(62)37-18-15-19-56(37)46(66)67-47(7,8)9/h12-14,16-17,24,28-31,34-40,57-60H,11,15,18-23,25-27H2,1-10H3,(H,49,50)(H,51,63)(H,52,62)(H,53,61)(H,54,64)/t31-,34+,35-,36-,37-,38-,39-,40-/m0/s1

Standard InChI Key:  CFRMVYLVKVUAHT-BXJXOLQHSA-N

Associated Targets(non-human)

Renin 163 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 943.20Molecular Weight (Monoisotopic): 942.5790AlogP: 1.82#Rotatable Bonds: 25
Polar Surface Area: 275.85Molecular Species: NEUTRALHBA: 12HBD: 9
#RO5 Violations: 3HBA (Lipinski): 19HBD (Lipinski): 9#RO5 Violations (Lipinski): 3
CX Acidic pKa: 11.95CX Basic pKa: 6.53CX LogP: 1.42CX LogD: 1.37
Aromatic Rings: 2Heavy Atoms: 67QED Weighted: 0.07Np Likeness Score: 0.04

References

1. Bundy GL, Pals DT, Lawson JA, Couch SJ, Lipton MF, Mauragis MA..  (1990)  Potent renin inhibitory peptides containing hydrophilic end groups.,  33  (8): [PMID:2197413] [10.1021/jm00170a036]

Source